119 related articles for article (PubMed ID: 6535646)
1. A gene controlling teratocarcinoma graft rejection mapped inside the t0 haplotype.
Gregorová S; Loudová M; Forejt J
Cell Differ; 1984 Dec; 15(2-4):235-9. PubMed ID: 6535646
[TBL] [Abstract][Full Text] [Related]
2. Establishment of a pluripotent embryonal carcinoma cell line not expressing SSEA-1 and ECMA-7 phenotypes.
Gregorová S; Loudová M; Dohnal K; Nosek J; Forejt J
Cell Differ; 1984 Dec; 15(2-4):87-92. PubMed ID: 6152581
[TBL] [Abstract][Full Text] [Related]
3. H-2 class I antigen expression on mouse teratocarcinoma cell lines.
Démant P; Oudshoorn-Snoek M
Immunogenetics; 1985; 22(6):543-52. PubMed ID: 4077148
[TBL] [Abstract][Full Text] [Related]
4. Teratocarcinoma transplantation rejection loci: genetic localization of the Gt-1 locus on chromosome 17 and the expression of alternate alleles.
Levine AJ; Teresky AK
Immunogenetics; 1981; 13(5):405-12. PubMed ID: 7298085
[TBL] [Abstract][Full Text] [Related]
5. Mice coisogenically immunized against H-2 class I antigens on transfected L cells reject transplanted embryonal carcinoma cells.
Moser AR; Johnson LL; Dove WF
Immunogenetics; 1985; 22(6):533-41. PubMed ID: 4077147
[TBL] [Abstract][Full Text] [Related]
6. H-2 effects on cell-cell interactions in the response to single non-H-2 alloantigens. I. Donor H-2D region control of H-7.1-immunogenicity and lack of restriction in vivo.
Wettstein PJ; Haughton G; Frelinger JA
J Exp Med; 1977 Nov; 146(5):1346-55. PubMed ID: 336833
[TBL] [Abstract][Full Text] [Related]
7. Genetic mapping of the embryonal carcinoma transplantation resistance locus Gt(B6) to mouse Chromosome 8.
Muller AJ; Heiden KB; Teresky AK; Levine AJ
Immunogenetics; 1999 Oct; 49(11-12):949-56. PubMed ID: 10501837
[TBL] [Abstract][Full Text] [Related]
8. Transfected H-2Kb gene as a cause of embryonal carcinoma cell rejection in vivo.
Mosinger B; Forejt J
Immunogenetics; 1989; 29(4):269-72. PubMed ID: 2703260
[No Abstract] [Full Text] [Related]
9. Rejection of tumors in mice with severe combined immunodeficiency syndrome determined by the major histocompatibility complex. Class I expression on the graft.
Glas R; Waldenström M; Höglund P; Klein G; Kärre K; Ljunggren HG
Cancer Res; 1995 May; 55(9):1911-6. PubMed ID: 7728758
[TBL] [Abstract][Full Text] [Related]
10. Genetics of teratocarcinoma transplantation. III. Genetic control of resistance to F9 tumor formation in allogeneic hosts.
Avner P; Simmler MC
J Reprod Immunol; 1982 Feb; 4(1):31-7. PubMed ID: 7069666
[TBL] [Abstract][Full Text] [Related]
11. Growth and differentiation of an embryonal carcinoma cell line (C145b).
Papaioannou VE; Evans EP; Gardner RL; Graham CF
J Embryol Exp Morphol; 1979 Dec; 54():277-95. PubMed ID: 528871
[TBL] [Abstract][Full Text] [Related]
12. Altered differentiation, indefinite growth potential, diminished tumorigenicity, and suppressed chimerization potential of hybrids between mouse teratocarcinoma cells and thymocytes.
Martin GM; Ogburn CE; Au K; Disteche CM
J Exp Pathol; 1984; 1(2):103-33. PubMed ID: 6599936
[TBL] [Abstract][Full Text] [Related]
13. Normal genetically mosaic mice produced from malignant teratocarcinoma cells.
Mintz B; Illmensee K
Proc Natl Acad Sci U S A; 1975 Sep; 72(9):3585-9. PubMed ID: 1059147
[TBL] [Abstract][Full Text] [Related]
14. Histocompatibility antigens controlled by the I region of the murine H-2 complex. I. Mapping of H-2A and H-2C loci.
Klein J; Geib R; Chiang C; Hauptfeld V
J Exp Med; 1976 Jun; 143(6):1439-52. PubMed ID: 775014
[TBL] [Abstract][Full Text] [Related]
15. Genetics of teratocarcinoma transplantation. II. Effect of a semidominant H-2-linked gene lying outside the immediate major histocompatibility complex on tumor formation by the embryonal carcinoma cell line F9 in H-2 congenic pairs.
Avner P
Transplantation; 1980 Sep; 30(3):185-90. PubMed ID: 14582174
[TBL] [Abstract][Full Text] [Related]
16. Other mammalian histocompatibility systems. Skin graft rejection and graft-versus-host reaction across I-subregion differences: are there many more than three H loci within the H-2 complex?
Götze D; Rössler R; Thierfelder S
Transplant Proc; 1977 Mar; 9(1):547-50. PubMed ID: 17198
[TBL] [Abstract][Full Text] [Related]
17. Rejection by syngeneic mice of cell variants obtained by mutagenesis of a malignant teratocarcinoma cell line.
Boon T; Kellermann O
Proc Natl Acad Sci U S A; 1977 Jan; 74(1):272-5. PubMed ID: 264681
[TBL] [Abstract][Full Text] [Related]
18. Cell-surface antigens of a clonal human embryonal carcinoma cell line: morphological and antigenic differentiation in culture.
Andrews PW; Goodfellow PN; Shevinsky LH; Bronson DL; Knowles BB
Int J Cancer; 1982 May; 29(5):523-31. PubMed ID: 7095898
[TBL] [Abstract][Full Text] [Related]
19. Histoincompatibility-associated differences in the phenotypes of murine cardiac allograft infiltrating T cells.
Carlquist JF; Shelby J; Hammond EH; Greenwood JH; Anderson JL
Immunology; 1994 May; 82(1):149-53. PubMed ID: 7913913
[TBL] [Abstract][Full Text] [Related]
20. Chimeric mice derived from human-mouse hybrid cells.
Illmensee K; Hoppe PC; Croce CM
Proc Natl Acad Sci U S A; 1978 Apr; 75(4):1914-8. PubMed ID: 205875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
